Physician

Adam Duvall, M.D.

According to 2025 Medicare claims, Adam Duvall, M.D. (NPI: 1285995266) practices hematopoietic cell transplantation and cellular therapy in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is UNIVERSITY OF CHICAGO (NPI: 1821048786; TIN: 36-2177139) and primary practice location at 60637-1447. Duvall is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Duvall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 49 traditional Medicare patients, billed 320 HCPCS/CPT codes, and received $31,235 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 93 prescription claims across 13 beneficiaries totaling $1,015,688 in drug costs, led by Idhifa (Enasidenib Mesylate). Open Payments data shows 1 records totaling $525. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $6,002 and ending at $31,235. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,998 to $1,015,688. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.